lenvatinib has been researched along with betulin* in 1 studies
1 other study(ies) available for lenvatinib and betulin
| Article | Year |
|---|---|
SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Mice; Phenylurea Compounds; TOR Serine-Threonine Kinases | 2023 |